Ropes & Gray represented AvenCell Therapeutics in the transaction, and Wilson Sonsini Goodrich & Rosati advised Novo Holdings and F-Prime Capital on the transaction. AvenCell Therapeutics...
AvenCell Therapeutics’ $112 Million Series B Funding Round
Toku’s $7 Million Seed Series Investment Round
CMS Carey & Allende and Wilmer Cutler Pickering Hale and Dorr advised Toku, while Carey & Co. and Gunderson Dettmer advised F-Prime on the transaction. Toku closed...
Sipai Health Technology’s Hong Kong IPO and Listing
Clifford Chance advised the joint sponsors on the deal while O’Melveny represented Sipai Health Technology Co., Ltd, Eight Roads and F-Prime. The joint sponsors Morgan Stanley...
AviadoBio’s $80 Million Series A Financing
Bristows advised AviadoBio’s seed investors. AviadoBio raised $80 million in Series A financing to advance neurodegenerative gene therapy platform. AviadoBio is a pioneering gene therapy company focused...